198 related articles for article (PubMed ID: 34301924)
1. GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death.
Liu G; Yu J; Wu R; Shi L; Zhang X; Zhang W; Zhong X; Wang Y; Li H; Shen Y; Wu C; Yu R; Niu M; Liu X
Cell Death Dis; 2021 Jul; 12(8):733. PubMed ID: 34301924
[TBL] [Abstract][Full Text] [Related]
2. ER stress and UPR activation in glioblastoma: identification of a noncanonical PERK mechanism regulating GBM stem cells through SOX2 modulation.
Peñaranda-Fajardo NM; Meijer C; Liang Y; Dijkstra BM; Aguirre-Gamboa R; den Dunnen WFA; Kruyt FAE
Cell Death Dis; 2019 Sep; 10(10):690. PubMed ID: 31534165
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin Induces Unfolded Protein Response and Enhances Temozolomide-Induced Cell Death in Glioblastoma Cells.
Dastghaib S; Shojaei S; Mostafavi-Pour Z; Sharma P; Patterson JB; Samali A; Mokarram P; Ghavami S
Cells; 2020 Oct; 9(11):. PubMed ID: 33105603
[TBL] [Abstract][Full Text] [Related]
4. SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243.
Murai Y; Jo U; Murai J; Jenkins LM; Huang SN; Chakka S; Chen L; Cheng K; Fukuda S; Takebe N; Pommier Y
Cancer Res; 2021 Jun; 81(11):3067-3078. PubMed ID: 33863777
[TBL] [Abstract][Full Text] [Related]
5. GRP78 blockade overcomes intrinsic resistance to UBA1 inhibitor TAK-243 in glioblastoma.
Zhang X; Wu R; Tian C; Wang W; Zhou L; Guo T; Yu J; Wu C; Shen Y; Liu X; Yu R
Cell Death Discov; 2022 Mar; 8(1):133. PubMed ID: 35347123
[TBL] [Abstract][Full Text] [Related]
6. The endoplasmic reticulum stress/unfolded protein response in gliomagenesis, tumor progression and as a therapeutic target in glioblastoma.
Peñaranda Fajardo NM; Meijer C; Kruyt FA
Biochem Pharmacol; 2016 Oct; 118():1-8. PubMed ID: 27106078
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.
Barghout SH; Patel PS; Wang X; Xu GW; Kavanagh S; Halgas O; Zarabi SF; Gronda M; Hurren R; Jeyaraju DV; MacLean N; Brennan S; Hyer ML; Berger A; Traore T; Milhollen M; Smith AC; Minden MD; Pai EF; Hakem R; Schimmer AD
Leukemia; 2019 Jan; 33(1):37-51. PubMed ID: 29884901
[TBL] [Abstract][Full Text] [Related]
8. Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells.
Best S; Hashiguchi T; Kittai A; Bruss N; Paiva C; Okada C; Liu T; Berger A; Danilov AV
Blood Adv; 2019 Jan; 3(1):51-62. PubMed ID: 30617217
[TBL] [Abstract][Full Text] [Related]
9. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development.
Kong Y; Ai C; Dong F; Xia X; Zhao X; Yang C; Kang C; Zhou Y; Zhao Q; Sun X; Wu X
Cell Cycle; 2018; 17(10):1199-1211. PubMed ID: 29886801
[TBL] [Abstract][Full Text] [Related]
10. Cycloheximide promotes paraptosis induced by inhibition of cyclophilins in glioblastoma multiforme.
Wang L; Gundelach JH; Bram RJ
Cell Death Dis; 2017 May; 8(5):e2807. PubMed ID: 28518150
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
Bijangi-Vishehsaraei K; Reza Saadatzadeh M; Wang H; Nguyen A; Kamocka MM; Cai W; Cohen-Gadol AA; Halum SL; Sarkaria JN; Pollok KE; Safa AR
J Neurosurg; 2017 Dec; 127(6):1219-1230. PubMed ID: 28059653
[TBL] [Abstract][Full Text] [Related]
13. 2,5-Dimethyl Celecoxib Inhibits Proliferation and Cell Cycle and Induces Apoptosis in Glioblastoma by Suppressing CIP2A/PP2A/Akt Signaling Axis.
Gao D; Nyalali AMK; Hou Y; Xu Y; Zhou J; Zhao W; Huang B; Li F
J Mol Neurosci; 2021 Aug; 71(8):1703-1713. PubMed ID: 33400072
[TBL] [Abstract][Full Text] [Related]
14. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response.
Lee D; Sun S; Ho AS; Kiang KM; Zhang XQ; Xu FF; Leung GK
Anticancer Res; 2014 Jun; 34(6):2957-66. PubMed ID: 24922660
[TBL] [Abstract][Full Text] [Related]
15. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
16. A curcumin derivative hydrazinobenzoylcurcumin suppresses stem-like features of glioblastoma cells by targeting Ca
Shin HJ; Lee S; Jung HJ
J Cell Biochem; 2019 Apr; 120(4):6741-6752. PubMed ID: 30390339
[TBL] [Abstract][Full Text] [Related]
17. FKBP9 promotes the malignant behavior of glioblastoma cells and confers resistance to endoplasmic reticulum stress inducers.
Xu H; Liu P; Yan Y; Fang K; Liang D; Hou X; Zhang X; Wu S; Ma J; Wang R; Li T; Piao H; Meng S
J Exp Clin Cancer Res; 2020 Feb; 39(1):44. PubMed ID: 32111229
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.
Daniele S; Costa B; Zappelli E; Da Pozzo E; Sestito S; Nesi G; Campiglia P; Marinelli L; Novellino E; Rapposelli S; Martini C
Sci Rep; 2015 Apr; 5():9956. PubMed ID: 25898313
[TBL] [Abstract][Full Text] [Related]
19. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
Buontempo F; Orsini E; Lonetti A; Cappellini A; Chiarini F; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; Bertacchini J; Neri LM; McCubrey JA; Martelli AM
Oncotarget; 2016 Jan; 7(2):1323-40. PubMed ID: 26593250
[TBL] [Abstract][Full Text] [Related]
20. Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
Sareddy GR; Viswanadhapalli S; Surapaneni P; Suzuki T; Brenner A; Vadlamudi RK
Oncogene; 2017 Apr; 36(17):2423-2434. PubMed ID: 27893719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
